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8S Abstracts June Supplement 2014anesthesia was used for 67% of the repairs compared with
33% done under general anesthesia.
Conclusions: This is the largest number of reported
case series in patients with aAVF aneurysmal-related com-
plications who underwent aneurysmorrhaphy. Surgical
aneurysmorrhaphy is a highly successful repair that will pre-
serve the native AVF and extend its functional life with very
low complications. Diligence has to be taken to evaluate
and treat for central venous stenosis to maintain use of
the AVF and prevent recurrence of further aneurysms.
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Objectives: Avoidance of stents within the venous cir-
cuit of an arteriovenous (AV) access is well accepted. The
challenge facing the access surgeon in caring for the patient
with a failing hemodialysis access is to determine the
optimal time to create a new access. We reviewed our
data, with our “stent-aversion” policy in an effort to answer
this question.
Methods: Data from consecutive patients treated in
our facility from May 2012 to September 2013 were
reviewed. Time to ﬁrst AV access failure was measured as
the time between the date of the procedure and failure
or last follow-up. The proportion of AV access failure was
compared in the two groups using the c2 test. A Cox pro-
portional hazards regression model was used to evaluate
the risk of failure by group.
Results: A total of 170 patients had complete data
available for review. Ninety-two patients (54%) were
treated with angioplasty alone, and 78 (46%) underwent
angioplasty and stent placement. Patency was continually
evaluated, and all patients underwent a clinical examina-
tion at 90 days with ﬁstulography used as needed. Average
age was 66.9 years (standard deviation, 13.9), with 51%
males. Median follow-up time was 8.5 months. The overall
proportion of failure was 19%: 12% in the angioplasty
group vs 27% in the stent group (P ¼ .013. Results from
Cox regression showed that patients in the stent group
had signiﬁcantly higher risk of failure (hazard ratio, 2.47;
95% conﬁdence interval, 1.15-5.33; P ¼ .021). Higher
risk of failure was also signiﬁcantly associated with
increased number of comorbidities (hazard ratio, 1.40;
P ¼ .020). Kaplan Meier results showed that the 9-month
failure rate was 12% in angioplasty group vs 33% in the
stent group.
Conclusions: This review conﬁrms the inferiority of
stents in the management of the failing hemodialysis access.
We advocate for the planning of new access creation at the
time a stent is placed into the AV access circuit to reduce
the need for further interventions.
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Objectives: The Society for Vascular Surgery (SVS)
recommends annual imaging after endovascular aneurysm
repair (EVAR). We sought to describe adherence to these
surveillance guidelines and determine the association be-
tween adherence and long-term outcomes.
Methods: We analyzed fee-for-service Medicare
claims for patients receiving EVAR from 2002 to 2005,
collecting all relevant postoperative images through 2011.
Allowing for a grace period of 3 months, we deﬁned com-
plete surveillance as at least one CT or ultrasound assess-
ment every 15 months after EVAR. Outcomes included
all-cause mortality, late rupture, and complications (con-
version to open, proximal or distal extension cuff, angio-
plasty, or embolization).
Results: Our cohort comprised 9503 patients. Median
follow-up duration was 5.5 (interquartile range, 2.6-7.2)
years. Incomplete surveillance was observed in 54.7% of pa-
tients, and was observed at 3.26 1.7 years after EVAR. Pa-
tients with incomplete surveillance had lower all-cause
mortality (45.8% vs 68.2%, P < .001), fewer late ruptures
(0.8% vs 1.4%, P ¼ .003), and fewer complications (1.6%
vs 6.2%, P < .001). Aneurysm-related mortality was equiv-
alent (0.7%) for both groups and was not associated with
incomplete surveillance by multivariable logistic regression
(adjusted odds ratio, 0.95; 95% conﬁdence interval, 0.58-
1.55, P ¼ .8). Those with incomplete surveillance had
longer intervals from EVAR to late rupture (5.24 vs 3.48
years, P < .001), complications (4.10 vs 1.78 years, P <
.001), and all-cause mortality (5.20 vs 2.85 years, P <
.001). Incomplete surveillance was associated with a lower
total cost ($9353 6 $9774 vs $9948 6 $12,628,
P < .001) and lower cost per year ($1471 6 $1436 vs
$3043 6 $3222, P < .001).
Conclusions: Nonadherence to SVS guidelines for
post-EVAR imaging was not associated with poor out-
comes. Our ﬁndings suggest the need for improved criteria
for deﬁning optimal surveillance intervals to achieve desired
outcomes while reducing unnecessary cost and resource
utilization.
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Objectives: To evaluate renal artery (RA) and acces-
sory RA (ARA) anatomy and implications for endovascular
repair with fenestrated, branched, or parallel (chimney,
snorkel, and periscope) stent graft techniques.
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was analyzed in 520 consecutive patients treated by open
or fenestrated endovascular repair for complex abdominal
aortic aneurysms (AAAs, 2000-2012). RA/ARA anatomy
was assessed using diameter, length, angles, and kidney
perfusion based on analysis of volumetric kidney paren-
chyma (VKP, Fig). Endovascular suitability was deter-
mined by RA diameter $4 mm, length to RA bifurcation
$13 mm, and preservation of >60% of one or >75% of
both kidneys by VKP analysis.
Results: There were 222 juxtarenal (43%), 241 supra-
renal (46%), and 57 type IV thoracoabdominal aortic aneu-
rysms (11%). A total of 1009 RAs and 176 ARAs were
analyzed. Endovascular incorporation was possible in 884
RAs (88%) and in 30 ARAs (17%). Using the proposed
criteria, 97 patients (19%) had one or more factors
rendering RA incorporation unsuitable, including early
bifurcation in 45 (9%), small diameter in 29 (6%), or
inability to preserve kidney parenchyma in 28 (5%). A total
of 170 patients (33%) had other anatomic issues that would
increase technical difﬁculty to RA incorporation, including
excessive downward angulation in 125 (24%), high-grade
stenosis in 51 (10%), or prior renal stents in 11 (2%).
Conclusions: Independent of the endovascular tech-
nique selected to treat a complex AAA, one of ﬁve patients
(19%) is not a candidate and one-third have anatomic chal-
lenges (33%) for RA incorporation. Patients with unsuit-
able RA anatomy may need open repair to maximize
renal artery patency and preserve renal function.
Fig.
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Objectives: The natural history of renal artery aneu-
rysms (RAAs) is not well documented. We present an 18-
year experience of patients with untreated RAAs.
Methods: A retrospective review was performed for
patients with RAAs (1995 to 2013). Patients who wereobserved and had at least two studies (computed tomogra-
phy/magnetic resonance imaging) were included. Signiﬁ-
cant aneurysm growth was deﬁned as >3 mm.
Results: Seventy-one aneurysms were analyzed. Mean
age on presentation was 69.76 12.3 years, and 63.4% were
female. Mean initial diameter was 1.29 6 0.54 cm (range,
0.5-3.7 cm). There was a mean of 2.8 studies per patient;
mean follow-up was 33.2 6 32.4 months. Detailed clinical
information was available in 48 patients. The most com-
mon comorbidities were hypertension (79%), hyperlipid-
emia (50%), and a smoking history (48%); 16.7% had
renal insufﬁciency, and 17% had other arterial aneurysms.
Among the cohort, the mean annual growth rate was
0.077 6 0.023 cm. Only four of 71 (5.6%) grew >3 mm
during the study period. By survival analysis, gender was
not a risk factor for growth (P ¼ .08). Only smoking was
found to be a signiﬁcant risk factor for growth; current
smokers were signiﬁcantly more likely to have growth >3
mm than former smokers or nonsmokers (30% incidence
of growth among current smokers vs 8.3% and 0% respec-
tively; P < .02). Survival analysis demonstrated that larger
aneurysms (>1.5 cm at presentation) had signiﬁcantly less
freedom from growth than smaller aneurysms (P ¼ .009).
There were no known ruptures, and no patient required
RAA intervention.
Conclusions: Small RAAs exhibit a slow annual
growth rate. Active smokers and those with a >1.5 cm
diameter on presentation may have more rapid growth.
In particular, current smokers have a high incidence
(30%) of clinically meaningful aneurysm growth. Neverthe-
less, this relatively large and longer-term natural history
study of observed RAAs supports observation for most
small RAAs in patients who do not have a clear indication
for surgical repair.
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Objectives: A substantial number of patients with
threatened arteriovenous (AV) access are found to have ste-
noses at the costoclavicular junction (CCJ), which
frequently are resistant to angioplasty and stenting. We hy-
pothesized that stenoses in this location will not resolve un-
less bony decompression is performed to relieve the
extrinsic venous compression.
Methods: We reviewed a prospectively maintained
database to identify all patients with threatened AV access
operated on for stenoses at the CCJ.
Results: Between July 2012 in December 2013, 24
patients with threatened access were operated on for CCJ
stenoses at our institution. Fifteen had highly dysfunctional
AV ﬁstulas otherwise felt to need ligation, 10 had signiﬁ-
cant arm and or head swelling, and three required access
but had no contralateral options. In six patients, the
